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ABSTRACT   Diisopropyl genistein-7-yl phosphate (C21H23O8P, Mr = 434.11) has been synthe- 
sized by a facile phosphorylated reaction with genistein and diisopropyl phosphite, and its structure 
was determined by IR, NMR, HR MS and X-ray single-crystal diffraction. The crystal belongs to 
monoclinic, space group P21/n, with a = 9.0690(18), b = 9.0412(18), c = 26.544(5) Å, β = 99.44(3)°, 
V = 2147.0(7) Å3, Z = 4, Dc = 1.344 Mg/m3, µ = 0.172 mm-1, F(000) = 912, the final R = 0.0545 and 
wR = 0.1352. In the crystal structure, the title compound is constructed by both intramolecular 
(O–H···O=C) and intermolecular (O–H···O=P) hydrogen bonding as well as π-π stacking interaction. 
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1  INTRODUCTION 
 
Genistein (5,7-dihydroxy-3-(4-hydroxyphenyl) 
chromen-4-one), a major metabolite of soy, is re- 
ported to have many biological activities including 
anti-inflammatory[1], antiestrogenic[2], antioxidant[3], 
antiproliferative[4], antiallergic[5], antiviral[6], antibac- 
terial effects[7], etc. Furthermore, genistein has de- 
monstrated anticancer activities[8, 9]. In recent years, 
there has been growing interest in genistein as anti- 
cancer substance with high efficacy, low toxicity, 
and minimum side effects[10]. However, the low 
absorbance of genistein in intestines results in its 
low biological activities. It is well known that the 
introduction of phosphate group into organic mo- 
lecules can often dramatically change their physical 
and chemical properties, or improve their biological 
activities[11, 12]. In order to obtain an efficient analo- 
gue to improve the biological activities of genistein, 
phosphate group was introduced. Diisopropyl geni- 
stein-7-yl phosphate was synthesized with a high 
yield in a facile phosphorylated reaction of genistein 
with diisopropyl phosphite, and its structure was 
determined by IR, NMR, HR MS and X-ray single- 
crystal diffraction.  
 
2  EXPERIMENTAL 
 
2. 1  Synthesis 
IR spectra were recorded on a Shimadazu IR-408 
Fourier spectrometer (KBr pellet). High resolution 
mass spectra (HR MS) were obtained on a Waters 
Micromass Q-Tof MicroTM instrument using the ESI 
technique. Melting points were obtained with an  
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XT-4 micromelting apparatus and uncorrected. NMR 
spectra were recorded on a Bruker Avance 400 MHz 
spectrometer. 1H and 13C chemical shifts were 
quoted in parts per million downfield from TMS. 31P 
chemical shifts are quoted in parts per million rela- 
tive to an external 85% H3PO4 standard. 
A solution of genistein (0.3 g, 1.1 mmol) and 
triethylamine (0.16 mL, 1.1 mmol) in ethanol (25 
mL) was stirred at 0～5 ℃ for 20 min, and a mixed 
solution of diisopropyl phosphite (0.2 g, 1.2 mmol) 
and tetrachloride (5 mL) was added dropwise to the 
solution over a period of 30 min. After 1 h, the reac- 
tion was heated to room temperature and stirred. The 
formation of the product was monitored by TLC. 
After completion of the reaction, the solution was 
filtered and evaporated to dryness, and the residue 
was purified by column chromatography on silica 
gel (chloroform:ethanol = 10:1). Single crystal was 
obtained by slow crystallization from an ethanol 
solution at room temperature. Yield: 81%, m.p.: 
162.5～163.5 ℃. HR MS 435.1203 [M + H]+, 
(calculated for C21H24O8P 435.1209). IR(KBr) 
v(cm-1): 3250 (O–H), 2985 (CH3), 1655 (C=O), 
1244 (P=O), 1018 (P–O). 1H NMR (CDCl3) δ: 12.84 
(s, 1H, OH-5), 7.84 (s, 1H, H-2), 7.24 (d, 3JH-H = 7.2 
Hz, 2H, H-2΄, 6΄), 6.79 (d, 4JH-H = 2.8 Hz, 1H, H-8), 
6.75 (d, 3JH-H = 8.0 Hz, 2H, H-3΄, 5΄), 6.63 (d, 4JH-H 
= 2.4 Hz, 1H, H-6), 4.82 (m, 2H, 2CH(CH3)2), 1.42 
(m, 12H, 2CH(CH3)2); 13C NMR (CDCl3) δ: 181.1 
(C-4), 162.7 (C-5), 157.1 (C-4΄), 156.9 (C-7), 155.7 
(C-9), 153.3 (C-2), 129.5 (C-2΄, 6΄), 123.7 (C-1΄), 
121.4 (C-3), 115.6 (C-3΄, 5΄), 108.9 (C-10), 104.0 
(C-6), 99.3 (C-8), 74.7 (d, 2JP-C = 6.2 Hz, CH(CH3)2), 
23.6 (CH(CH3)2); 31P NMR (CDCl3) δ: –8.2.  



































Scheme 1.  Synthesis of diisopropyl genistein-7-yl phosphate (2) 
 
2. 2  Crystal data and structure determination 
A colorless single crystal (0.20nm × 0.18nm × 
0.17nm) of compound 2 was selected and mounted 
on the top of a glass fiber. The data were collected 
on an R-Axis-IV diffractometer equipped with a gra- 
phite-monochromatic MoKα radiation (λ = 0.71073 
Å) using an oscillation frames scan mode in the 
range of 1.56<θ<25.00° at 291(2) K. A total of 6041 
reflections were recorded and 3491 were unique  
(Rint = 0.0378), among which 2736 (0≤h≤10, –10
≤k≤10, –31≤l≤30) were observed. The unit cell 
dimensions were obtained with the least-squares 
refinements. The structure was solved by direct 
methods with SHELXS-97 program[13] and refined 
by full-matrix least-squares method on F2 with 
anisotropic thermal parameters for all non-hydrogen 
atoms using SHELXL-97[14]. Hydrogen atoms were 
generated geometrically. The final cycle of refine- 
ment converged to R = 0.0756, wR = 0.1471 (w = 
1/[σ2(Fo2) + (0.0734P)2 + 0.6267P], where P = (Fo2 
+ 2Fc2)/3), S = 1.073, (∆/σ)max = 0.000, (∆ρ)max = 
0.279 and (∆ρ)min = –0.241 e/Å3. Molecular illustra- 
tions were prepared using the XP package.  
 
3  RESULTS AND DISCUSSION 
 
Compound 2 was synthesized using a facile phos- 
phorylated reaction with genistein and diisopropyl 
phosphate (Scheme 1). The results showed that the 
phosphorylation action occurred regioselectively 
only at the hydroxyl group of 7 position of genistein, 
leaving the 4΄- and 5-hydroxyl groups unphosphory- 
lated. For example, 13C NMR of compound 2 show- 
ed that the chemical shifts from 4΄-C and 5-C were 
nearly not variable compared to those of genistein; 
whereas, the chemical shift (δ 156.9) from 7-C of 
compound 2 was 7.4 ppm decreased related to 7-C 
(δ 164.3) of genistein. This explains that the phos- 
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phorylation proceeds a regioselective attack at 7-OH 
of genistein. X-ray crystal structure of compound 2 
further proved this fact. 
The selected bond lengths and bond angles are 
shown in Tables 1 and 2, respectively. The molecular 
structure of compound 2 is depicted in Fig. 1, and 
the hydrogen bonds in the crystal of 2 in Fig. 2. 
 
Table 1.  Selected Bond Lengths (Å) in the Molecule of 2  
Bond Dist. Bond Dist. Bond Dist. 
P(1)–O(1) 1.459(2) O(4)–C(3) 1.402(3) O(3)–C(19) 1.480(4) 
P(1)–O(3) 1.541(2) O(5)–C(9) 1.352(3) O(8)–C(13) 1.370(3) 
P(1)–O(2) 1.545(2) O(5)–C(5) 1.364(3) C(1)–C(6) 1.414(4) 
P(1)–O(4) 1.584(2) O(6)–C(1) 1.353(3) C(8)–C(9) 1.350(4) 
O(2)–C(16) 1.488(4) O(7)–C(7) 1.251(3) C(8)–C(10) 1.477(4) 
 
Table 2.  Selected Bond Angles and Torsion Angles in the Molecule of 2   
Angle (o) Angle (o) Angle (o) 
O(1)–P(1)–O(3) 115.19(13) C(9)–O(5)–C(5) 118.5(2) O(8)–C(13)–C(14) 118.6(3) 
P(1)–O(3)–C(19) 120.0(2) O(6)–C(1)–C(2) 119.1(3) C(21)–C(19)–O(3) 107.5(3) 
P(1)–O(2)–C(16) 120.1(2) O(5)–C(5)–C(6) 120.5(2) C(7)–C(8)–C(10) 122.4(2) 
C(3)–O(4)–P(1) 121.65(18) O(7)–C(7)–C(6) 121.6(2) C(8)–C(9)–O(5) 126.8(3) 
O(1)–P(1)–O(2)–C(16) 45.4(3) O(1)–P(1)–O(3)–C(19) 55.4(3) C(2)–C(1)–C(6)–C(7) –176.4(2) 
O(1)–P(1)–O(4)–C(3) 32.5(3) C(3)–C(4)–C(5)–O(5) 178.2(2) C(9)–O(5)–C(5)–C(6) 3.0(4) 
O(3)–P(1)–O(4)–C(3) –92.7(2) O(5)–C(5)–C(6)–C(7) –1.2(4) O(7)–C(7)–C(8)–C(10) 0.8(4) 
O(2)–P(1)–O(4)–C(3) 158.8(2) P(1)–O(2)–C(16)–C(18) –124.1(4) C(5)–O(5)–C(9)–C(8) –2.8(4) 
C(1)–C(2)–C(3)–C(4) –0.7(4) P(1)–O(3)–C(19)–C(21) –132.0(3) C(9)–C(8)–C(10)–C(11) –133.4(3) 
 
Fig. 1.  View of the molecule of diisopropyl genistein 7-yl phosphate (2)  
Thermal ellipsoids are drawn at 30% probability level 
 
Fig. 2.  Hydrogen bonds in diisopropyl genistein-7-yl phosphate (2) 
 
X-ray single-crystal structure study revealed that 
hydroxyl group at the 7 position of genistein was 
phosphorylated, which is in good agreement with the 
information of IR and NMR data. The P=O bond 
length (1.459(2) Å) is close to those found in other 
related structures[15, 16]. The P(1)−O(3) (1.541(2) Å), 
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P(1)−O(2) (1.545(2) Å) and P(1)−O(4) (1.584(2) Å) 
bonds are longer than the typical P−O bond in 
NaHPO3NH2 (1.51 Å)[17]. The oxygen atoms (O(2), 
O(3) and O(4)) have sp2 hybridization character, and 
the P(1)−O(4)−C(3), P(1)−O(3)−C(19) and P(1)− 
O(2)−C(16) bond angles are 121.65(18), 120.0(2) 
and 120.1(2)o, respectively. The torsion angle of 
C(9)−C(8)−C(10)−C(11) is −133.4(3)o, which shows 
rings B (C(10)−C(11)−C(12)−C(13)−C(14)−C(15)) 
and C (O(5)−C(5)−C(6)−C(7)−C(8)−C(9)) are not 
coplanar. Furthermore, the C(2)−C(1)−C(6)−C(7) 
and C(6)−C(5)−O(5)−C(9) torsion angles are 
−176.4(2) and 3.0(4)o, respectively, so rings A 
(C(1)−C(2)−C(3)−C(4)−C(5)−C(6)) and C are not 
absolute planes.  
In the crystal of 2 (Fig. 2), an intramolecular hy- 
drogen bond can be observed between the hydroxyl 
group and the oxygen atom of carbonyl group: 
O(6)−H(7)···O(7)=C(7) 1.78(4) Å. Furthermore, the 
hydroxyl group at the 4΄ position of genistein forms 
an intermolecular hydrogen bond with the phos- 
phoryl group of the neighboring molecule: O(8)− 
H(8)···O(1) 1.85(4) Å. The parameters of primary 
hydrogen bonds are listed in Table 3. Hence, a 
centrosymmetric dimmer unit is constructed by the 
intermolecular hydrogen bond. Interestingly, rela- 
tively shorter centroid-to-centroid distance (Table 4) 
between the rings (Cg(1) --> Cg(1)) from adjacent 
molecules is also observed, implying the existence 
of π-π stacking interaction in the compound. The 
intramolecular and intermolecular hydrogen bonds 
together with π-π stacking interaction play important 
roles in stabilizing the structure.  
 
Table 3.  Hydrogen Bonding Geometry in the Crystal of 2  
D–H···A d(D–H) (Å) d(H···A) (Å) d(D···A) (Å) D–H···A (o) 
O(6)–H(7)···O(7) 0.86(4) 1.78(4) 2.587(3) 156(4) 
O(8)–H(8)···O(1)a 0.86(4) 1.85(4) 2.707(3) 177(4) 
       Symmetry code: a: –x, –y, –z 
 
Table 4.  Parameters Between the Planes  
Cg(I) --> Cg(J) Distance between ring Dihedral angle (°) Perpendicular distance Perpendicular distance 
Cg(1) --> Cg(1) 4.103 0.000 3.466 3.466 
Cg(1): O(5) --> C(1) --> C(2) --> C(3) --> C(4) --> C(5) --> C(6) --> C(7) --> C(8) --> C(9) 
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